Brought to you by 
Durata Therapeutics nets $71.8mm in IPO
11 Jun 2021
Executive Summary
Infectious disease-focused start-up Durata Therapeutics Inc. has netted $71.8mm through the sale of 8.6mm common shares (including the overallotment) at $9 each in its initial public offering. Durata had planned to sell 6.25mm common shares priced between $11 and $13.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Durata Therapeutics nets $71.8mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice